LataMed AI Hits 1,000 Subscribers, Advances Mobile Health Apps

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced continued progress on its mobile healthcare application ecosystem, with applications being prepared for future availability through both the Apple App Store and Google Play Store. The company, which focuses on telehealth infrastructure and healthcare analytics platforms for emerging markets, particularly Latin America, is developing applications to support telehealth, patient engagement, provider coordination, emergency response, and AI-assisted healthcare. Management stated that these efforts are part of a broader digital healthcare infrastructure strategy aimed at improving healthcare accessibility in underserved regions.

In a significant milestone, LataMed AI has surpassed 1,000 early-stage platform subscribers, reflecting early interest and engagement with its technology ecosystem. The company believes this user growth provides valuable operational feedback as development continues. Dr. Kevin Rodan Levy, CEO, emphasized the goal of expanding healthcare connectivity through both Apple and Android platforms, noting that surpassing 1,000 users is an encouraging step. However, the company cautioned that applications remain under development and have not been fully commercialized, with no assurance regarding release timing or regulatory progression.

The broader technology initiatives focus on scalable healthcare infrastructure for developing markets where access to digital healthcare tools is limited. LataMed AI plans to leverage its platform for remote patient engagement, analytics, and emergency response integration. The company’s stock trades on the OTC Markets under the symbol LMED. For more information, visit the company’s website at https://latamed.ai or follow its official Instagram page at https://www.instagram.com/latamedai.